Comorbidity measures for stroke outcome research

A preliminary study

Meigen Liu, Kazuhisa Domen, Naoichi Chino

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Objective: To develop standardized comorbidity measures for use in stroke outcome research. Design: Retrospective review of medical records to analyze comorbidities and to study reliability and validity of the newly developed measures, comorbidity index (CI), and weighted to morbidity index (w-CI). Setting: Tertiary rehabilitation center in Japan. Patients: 106 stroke patients, age 56.5 ± 13.2yr, admitted and discharged during the year from May 1994 to December 1995. The median days of duration of stroke, onset to admission, and length of stay (LOS) were 199.83, and 105.5, respectively. The median admission and discharge Functional Independence Measure (FIM) raw scores were 85 and 110, respectively. Main Outcome Measures: Assessment of interrater reliability with intraclass correlation coefficient (ICC) for total scores and weighted kappa for subscores: assessment of concurrent validity by relating the measures to Charlson's comorbidity index, total numbers of medications, laboratory studies, therapeutic interventions, consultations, and days of interruption (Spearman's rank correlation method): study of predictive validity with discharge FIM score and LOS as dependent variables. Results: The ICCs were .896 for CI and .997 for w-CI, and weighed kappa ranged from .615 to 1.00. CI and w-CI correlated significantly with Charlson index and the above indices of validity. They also correlated negatively with discharge FIM scores and positively with LOS. With stepwise multiple regression analysis, 79.8% of the variance of discharge FIM scores could he explained by w-CI, days from onset to admission, admission FIM score, and deviation in tape bisection task. Conclusion: The newly developed comorbidity measures are tellable and valid for use in stroke outcome research.

Original languageEnglish
Pages (from-to)166-172
Number of pages7
JournalArchives of Physical Medicine and Rehabilitation
Volume78
Issue number2
DOIs
Publication statusPublished - 1997 Feb

Fingerprint

Comorbidity
Stroke
Outcome Assessment (Health Care)
Length of Stay
Rehabilitation Centers
Reproducibility of Results
Medical Records
Japan
Referral and Consultation
Regression Analysis
Morbidity

ASJC Scopus subject areas

  • Rehabilitation

Cite this

Comorbidity measures for stroke outcome research : A preliminary study. / Liu, Meigen; Domen, Kazuhisa; Chino, Naoichi.

In: Archives of Physical Medicine and Rehabilitation, Vol. 78, No. 2, 02.1997, p. 166-172.

Research output: Contribution to journalArticle

@article{4ac6e6c318614ffd9a36862710c9a2f2,
title = "Comorbidity measures for stroke outcome research: A preliminary study",
abstract = "Objective: To develop standardized comorbidity measures for use in stroke outcome research. Design: Retrospective review of medical records to analyze comorbidities and to study reliability and validity of the newly developed measures, comorbidity index (CI), and weighted to morbidity index (w-CI). Setting: Tertiary rehabilitation center in Japan. Patients: 106 stroke patients, age 56.5 ± 13.2yr, admitted and discharged during the year from May 1994 to December 1995. The median days of duration of stroke, onset to admission, and length of stay (LOS) were 199.83, and 105.5, respectively. The median admission and discharge Functional Independence Measure (FIM) raw scores were 85 and 110, respectively. Main Outcome Measures: Assessment of interrater reliability with intraclass correlation coefficient (ICC) for total scores and weighted kappa for subscores: assessment of concurrent validity by relating the measures to Charlson's comorbidity index, total numbers of medications, laboratory studies, therapeutic interventions, consultations, and days of interruption (Spearman's rank correlation method): study of predictive validity with discharge FIM score and LOS as dependent variables. Results: The ICCs were .896 for CI and .997 for w-CI, and weighed kappa ranged from .615 to 1.00. CI and w-CI correlated significantly with Charlson index and the above indices of validity. They also correlated negatively with discharge FIM scores and positively with LOS. With stepwise multiple regression analysis, 79.8{\%} of the variance of discharge FIM scores could he explained by w-CI, days from onset to admission, admission FIM score, and deviation in tape bisection task. Conclusion: The newly developed comorbidity measures are tellable and valid for use in stroke outcome research.",
author = "Meigen Liu and Kazuhisa Domen and Naoichi Chino",
year = "1997",
month = "2",
doi = "10.1016/S0003-9993(97)90259-8",
language = "English",
volume = "78",
pages = "166--172",
journal = "Archives of Physical Medicine and Rehabilitation",
issn = "0003-9993",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Comorbidity measures for stroke outcome research

T2 - A preliminary study

AU - Liu, Meigen

AU - Domen, Kazuhisa

AU - Chino, Naoichi

PY - 1997/2

Y1 - 1997/2

N2 - Objective: To develop standardized comorbidity measures for use in stroke outcome research. Design: Retrospective review of medical records to analyze comorbidities and to study reliability and validity of the newly developed measures, comorbidity index (CI), and weighted to morbidity index (w-CI). Setting: Tertiary rehabilitation center in Japan. Patients: 106 stroke patients, age 56.5 ± 13.2yr, admitted and discharged during the year from May 1994 to December 1995. The median days of duration of stroke, onset to admission, and length of stay (LOS) were 199.83, and 105.5, respectively. The median admission and discharge Functional Independence Measure (FIM) raw scores were 85 and 110, respectively. Main Outcome Measures: Assessment of interrater reliability with intraclass correlation coefficient (ICC) for total scores and weighted kappa for subscores: assessment of concurrent validity by relating the measures to Charlson's comorbidity index, total numbers of medications, laboratory studies, therapeutic interventions, consultations, and days of interruption (Spearman's rank correlation method): study of predictive validity with discharge FIM score and LOS as dependent variables. Results: The ICCs were .896 for CI and .997 for w-CI, and weighed kappa ranged from .615 to 1.00. CI and w-CI correlated significantly with Charlson index and the above indices of validity. They also correlated negatively with discharge FIM scores and positively with LOS. With stepwise multiple regression analysis, 79.8% of the variance of discharge FIM scores could he explained by w-CI, days from onset to admission, admission FIM score, and deviation in tape bisection task. Conclusion: The newly developed comorbidity measures are tellable and valid for use in stroke outcome research.

AB - Objective: To develop standardized comorbidity measures for use in stroke outcome research. Design: Retrospective review of medical records to analyze comorbidities and to study reliability and validity of the newly developed measures, comorbidity index (CI), and weighted to morbidity index (w-CI). Setting: Tertiary rehabilitation center in Japan. Patients: 106 stroke patients, age 56.5 ± 13.2yr, admitted and discharged during the year from May 1994 to December 1995. The median days of duration of stroke, onset to admission, and length of stay (LOS) were 199.83, and 105.5, respectively. The median admission and discharge Functional Independence Measure (FIM) raw scores were 85 and 110, respectively. Main Outcome Measures: Assessment of interrater reliability with intraclass correlation coefficient (ICC) for total scores and weighted kappa for subscores: assessment of concurrent validity by relating the measures to Charlson's comorbidity index, total numbers of medications, laboratory studies, therapeutic interventions, consultations, and days of interruption (Spearman's rank correlation method): study of predictive validity with discharge FIM score and LOS as dependent variables. Results: The ICCs were .896 for CI and .997 for w-CI, and weighed kappa ranged from .615 to 1.00. CI and w-CI correlated significantly with Charlson index and the above indices of validity. They also correlated negatively with discharge FIM scores and positively with LOS. With stepwise multiple regression analysis, 79.8% of the variance of discharge FIM scores could he explained by w-CI, days from onset to admission, admission FIM score, and deviation in tape bisection task. Conclusion: The newly developed comorbidity measures are tellable and valid for use in stroke outcome research.

UR - http://www.scopus.com/inward/record.url?scp=0031047987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031047987&partnerID=8YFLogxK

U2 - 10.1016/S0003-9993(97)90259-8

DO - 10.1016/S0003-9993(97)90259-8

M3 - Article

VL - 78

SP - 166

EP - 172

JO - Archives of Physical Medicine and Rehabilitation

JF - Archives of Physical Medicine and Rehabilitation

SN - 0003-9993

IS - 2

ER -